Table 4.
Symptom Prevalence of Long COVID Patients.
| Ongoing Symptomatic COVID-19 | Post-COVID-19 Syndrome | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| SD | N | Min. | Max. | SD | N | Min. | Max. | |||
| Constitutional | ||||||||||
| Fatigue | 43% | 24 | 19 | 5% | 83% | 44% | 19 | 16 | 10% | 71% |
| Fever | 14% | 18 | 8 | 1% | 51% | 8% | 8 | 7 | 1% | 20% |
| Respiratory | ||||||||||
| Dyspnoea | 31% | 19 | 25 | 2% | 64% | 40% | 21 | 15 | 6% | 73% |
| Cough | 26% | 13 | 19 | 5% | 45% | 22% | 16 | 16 | 3% | 59% |
| Expectoration | 13% | 8 | 7 | 1% | 25% | - | - | - | - | - |
| Throat pain | 6% | 6 | 7 | 1% | 17% | 12% | 9 | 6 | 3% | 29% |
| Neurological | ||||||||||
| Sleep disorder | 36% | 25 | 5 | 10% | 69% | 33% | 13 | 11 | 18% | 57% |
| Headache | 17% | 8 | 10 | 4% | 36% | - | - | - | - | - |
| Anosmia | 11% | 7 | 9 | 2% | 21% | 10% | 3 | 8 | 5% | 13% |
| Ageusia | 11% | 9 | 8 | 1% | 25% | 8% | 4 | 7 | 2% | 15% |
| Confusion | 11% | 3 | 3 | 9% | 14% | - | - | - | - | - |
| Cardiovascular | ||||||||||
| Chest pain | 17% | 11 | 9 | 3% | 35% | 10% | 6 | 11 | 1% | 22% |
| Palpitations | 6% | 4 | 5 | 2% | 11% | 20% | 28 | 4 | 4% | 62% |
| Chest tightness | 4% | 3 | 3 | 1% | 6% | - | - | - | - | - |
| Gastrointestinal | ||||||||||
| Weight loss | 13% | 6 | 3 | 6% | 17% | - | - | - | - | - |
| Diarrhoea | 8% | 5 | 10 | 1% | 18% | - | - | - | - | - |
| Inappetence | 5% | 4 | 4 | 1% | 9% | - | - | - | - | - |
| Nausea | 2% | 2 | 5 | 1% | 6% | - | - | - | - | - |
| Ulcer | 2% | 1 | 3 | 1% | 3% | - | - | - | - | - |
| Musculoskeletal | ||||||||||
| Arthralgia | 23% | 13 | 7 | 10% | 48% | 13% | 11 | 4 | 6% | 29% |
| Myalgia | 18% | 10 | 9 | 1% | 32% | 34% | 31 | 9 | 2% | 86% |
| Dermatological | ||||||||||
| Skin problems | 12% | 4 | 3 | 8% | 15% | 6% | 4 | 4 | 3% | 12% |
| Eye irritation | 8% | 3 | 4 | 4% | 11% | - | - | - | - | - |
| Hair loss | - | - | - | - | - | 20% | 9 | 5 | 6% | 29% |
= mean. SD = standard deviation. N = number of assessment timepoints. Min. = minimum. Max. = maximum.